The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACADIA PHARMACEUTICALS INC | COM | 004225108 | 603 | 21,552 | SH | SOLE | 21,552 | 0 | 0 | ||
| ALEXION PHARMACEUTICALS INC | COM | 015351109 | 1,197 | 8,599 | SH | SOLE | 8,599 | 0 | 0 | ||
| ALIGN TECHNOLOGY INC | COM | 016255101 | 390 | 5,366 | SH | SOLE | 5,366 | 0 | 0 | ||
| ARATANA THERAPEUTICS INC | COM | 03874P101 | 1,206 | 218,515 | SH | SOLE | 218,515 | 0 | 0 | ||
| ATHENAHEALTH INC | COM | 04685W103 | 680 | 4,900 | SH | SOLE | 4,900 | 0 | 0 | ||
| DEXCOM INC | COM | 252131107 | 1,293 | 19,046 | SH | SOLE | 19,046 | 0 | 0 | ||
| EDWARDS LIFESCIENCES CORP | COM | 28176E108 | 1,539 | 17,443 | SH | SOLE | 17,443 | 0 | 0 | ||
| LILLY ELI & CO | COM | 532457108 | 1,931 | 26,810 | SH | SOLE | 26,810 | 0 | 0 | ||
| REGENERON PHARMACEUTICALS | COM | 75886F107 | 826 | 2,291 | SH | SOLE | 2,291 | 0 | 0 | ||